Chidamide, a histone deacetylase inhibitor, inhibits autophagy and exhibits therapeutic implication in chronic lymphocytic leukemia

Novel agents have made the management of chronic lymphocytic leukemia (CLL) more promising and personalized. However, long-term treatment is still warranted which may result in toxicity and resistance. Thus, new combination therapy may help achieve deeper remission and limited-duration therapy. Hist...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yi-Lin, Pan, Bi-Hui, Liang, Jin-Hua, Zhu, Hua-Yuan, Wang, Li, Xia, Yi, Wu, Jia-Zhu, Fan, Lei, Li, Jian-Yong, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485718/
https://www.ncbi.nlm.nih.gov/pubmed/32855355
http://dx.doi.org/10.18632/aging.103536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485718/
https://www.ncbi.nlm.nih.gov/pubmed/32855355
http://dx.doi.org/10.18632/aging.103536

Ejemplares similares